Effect of chronic olanzapine treatment on nerve growth factor and brain-derived neurotrophic factor in the rat brain

European Neuropsychopharmacology

Volumn 15, Issue 3, 2005, Pages 311-317

  Angelucci, Francesco ^a,b   Aloe, Luigi ^b   Iannitelli, Angela ^c   Gruber, Susanne H M ^a   Mathé, Aleksander A ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b CNR   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

BDNF; NGF; Olanzapine; Psychopharmacology; Rat brain; Schizophrenia

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DRINKING WATER; NERVE GROWTH FACTOR; NEUROLEPTIC AGENT; OLANZAPINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL SURVIVAL; CELLULAR DISTRIBUTION; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG MEGADOSE; FRONTAL CORTEX; HIPPOCAMPUS; HYPOTHALAMUS; LONG TERM CARE; NEUROMODULATION; NONHUMAN; OCCIPITAL CORTEX; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PSYCHOPHARMACOLOGY; RAT; RAT STRAIN; REGULATORY MECHANISM; SEROTONINERGIC NERVE CELL; TISSUE DISTRIBUTION;

EID: 16844363642     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2004.11.005     Document Type: Article

References (36)

1. G.K. Aghajanian, and G.J. Marek Serotonin model of schizophrenia: emerging role of glutamate mechanisms Brain Res. Brain Res. Rev. 31 2000 302 312
2. L. Aloe, A. Iannitelli, F. Angelucci, G. Bersani, and M. Fiore Studies in animal models and humans suggesting a role of nerve growth factor in schizophrenia-like disorders Behav. Pharmacol. 11 2000 235 242
3. C. Altar, and P.S. DiStefano Neurotrophin trafficking by anterograde transport Trends Neurosci. 21 1998 433 437
4. F. Angelucci, L. Aloe, S.H. Gruber, M. Fiore, and A.A. Mathé Chronic antipsychotic treatment selectively alters nerve growth factor and neuropeptide Y immunoreactivity and the distribution of choline acetyl transferase in rat brain regions Int. J. Neuropsychopharmacol. 3 2000 13 25
5. F. Angelucci, A.A. Mathé, and L. Aloe Brain-derived neurotrophic factor and tyrosine kinase receptor TrkB in rat brain are significantly altered after haloperidol and risperidone administration J. Neurosci. Res. 60 2000 783 794
6. F. Angelucci, A.A. Mathé, and L. Aloe Neurotrophic factors and CNS disorders: findings in rodent models of depression and schizophrenia Prog. Brain Res. 146 2004 151 165
7. C.M. Beasley Jr., T. Sanger, W. Satterlee, G. Tollefson, P. Tran, and S. Hamilton Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trial Psychopharmacology 124 1996 159 167
8. C.R. Bowden, S.J. Voina, R. Woestenborghs, R. De Coster, and J. Heykants Stimulation by risperidone of rat prolactin secretion in vivo and in cultured pituitary cells in vitro J. Pharmacol. Exp. Ther. 262 1992 699 706
9. F.P. Bymaster, S.K. Hemrick-Luecke, K.W. Perry, and R.W. Fuller Neurochemical evidence for antagonism by olanzapine of dopamine, serotonin, alpha 1-adrenergic and muscarinic receptors in vivo in rats Psychopharmacology 124 1996 87 94
10. F. Bymaster, K.W. Perry, D.L. Nelson, D.T. Wong, K. Rasmussen, N.A. Moore, and D.O. Calligaro Olanzapine: a basic science update Br. J. Psychiatr., Suppl. 37 1999 36 40
11. L. Calzà, L. Giardino, and L. Aloe NGF content and expression in the rat pituitary gland and regulation by thyroid hormone Brain Res. Mol. Brain Res. 51 1997 60 68
12. J. Chlan-Fourney, P. Ashe, K. Nylen, A.V. Juorio, and X.M. Li Differential regulation of hippocampal BDNF mRNA by typical and atypical antipsychotic administration Brain Res. 954 2002 11 20
13. M. Fiore, J. Korf, F. Angelucci, L. Talamini, and L. Aloe Prenatal exposure to methylazoxymethanol acetate in the rat alters neurotrophin levels and behavior: considerations for neurodevelopmental diseases Physiol. Behav. 71 2000 57 67
14. F. Fumagalli, R. Molteni, M. Roceri, F. Bedogni, R. Cantero, C. Fossati, M. Pennarelli, G. Racagni, and M.A. Riva Effect of antipsychotic drugs on brain-derived neurotrophic factor expression under reduced N-methyl-d-aspartate receptor activity J. Neurosci. Res. 72 2003 622 628
15. J. Glowinski, and L.L. Iversen Regional studies of catecholamines in the rat brain: I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain J. Neurochem. 13 1966 655 669
16. S. Iritani, K. Niizato, H. Nawa, K. Ikeda, and P.C. Emson Immunohistochemical study of brain-derived neurotrophic factor and its receptor, TrkB, in the hippocampal formation of schizophrenic brains Prog. Neuro-Psychopharmacol. Biol. Psychiatry 27 2003 801 807
17. S. Kapur, R.B. Zipursky, G. Remington, C. Jones, J. DaSilva, A.A. Wilson, and S. Houle 5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation Am. J. Psychiatry 155 1998 921 928
18. S. Korsching, R. Heumann, H. Thoenen, and F. Hefti Cholinergic denervation of the rat hippocampus by fimbrial transection leads to a transient accumulation of nerve growth factor (NGF) without change in mRNANGF content Neurosci. Lett. 66 1986 175 180
19. X.M. Li, K.W. Perry, D.T. Wong, and F.P. Bymaster Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum Psychopharmacology 136 1998 153 161
20. X.M. Li, J. Chlan-Fourney, A.V. Juorio, V.L. Bennet, S. Shrinkhande, D.L. Keegan, J. Qi, and A.A. Boulton Differential effects of olanzapine on the gene expression of superoxide dismutase and the low affinity nerve growth factor receptor J. Neurosci. Res. 56 1999 72 75
21. B.K. Lipska, Z.Z. Khaing, C.S. Weickert, and D.R. Weinberger BDNF mRNA expression in rat hippocampus and prefrontal cortex: effects of neonatal ventral hippocampal damage and antipsychotic drugs Eur. J. Neurosci. 14 2001 135 144
22. C. Missale, F. Boroni, S. Sigala, A. Buriani, M. Fabris, A. Leon, R. Dal Toso, and P. Spano Nerve growth factor in the anterior pituitary: localization in mammotroph cells and cosecretion with prolactin by a dopamine-regulated mechanism Proc. Natl. Acad. Sci. U. S. A 93 1996 4240 4245
23. N.A. Moore Olanzapine: preclinical pharmacology and recent findings Br. J. Psychiatr., Suppl. 37 1999 41 44
24. M. Nibuya, S. Morinobu, and R.S. Duman Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments J. Neurosci. 15 1995 7539 7547
25. V. Parikh, M.M. Khan, and S.P. Mahadik Olanzapine counteracts reduction of brain-derived neurotrophic factor and TrkB receptors in rat hippocampus produced by haloperidol Neurosci. Lett. 356 2004 135 139
26. J.C. Patterson, and G.V. Childs Nerve growth factor and its receptor in the anterior pituitary Endocrinology 135 1994 1689 1696
27. R.G. Petty Prolactin and antipsychotic medications: mechanism of action Schizophr. Res. 35 1999 S67 S73 (Suppl.)
28. S. Scaccianoce, K. Lombardo, R. Nicolai, D. Affricano, and L. Angelucci Studies on the involvement of histamine in the hypothalamic-pituitary-adrenal axis activation induced by nerve growth factor Life Sci. 67 2000 3143 3152
29. S.D. Skaper Nerve growth factor: a neurokine orchestrating neuroimmune-endocrine functions Mol. Neurobiol. 24 2001 183 199
30. M. Spitzer, R. Sajjad, and F. Benjamin Pattern of development of hyperprolactinemia after initiation of haloperidol therapy Obst. Gynaecol. 91 1998 693 695
31. M. Takahashi, O. Shirakawa, K. Toyooka, N. Kitamura, T. Hashimoto, K. Maeda, S. Koizumi, K. Wakabayashi, H. Takahashi, T. Someya, and H. Nawa Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients Mol. Psychiatry 5 2000 293 300
32. J. Thome, P. Foley, and P. Riederer Neurotrophic factors and the maldevelopmental hypothesis of schizophrenic psychoses. Review article J. Neural Transm. 105 1998 85 100
33. G.D. Tollefson, C.M. Beasley Jr., P.V. Tran, J.S. Street, J.A. Krueger, R.N. Tamura, K.A. Graffeo, and M.E. Thieme Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial Am. J. Psych. 154 1997 457 465
34. V.A. Vaidya, G.J. Marek, G.K. Aghajanian, and R.S. Duman 5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex J. Neurosci. 17 1997 2785 2795
35. C.G. Wakade, S.P. Mahadik, J.L. Waller, and F.C. Chiu Atypical neuroleptics stimulate neurogenesis in adult rat brain J. Neurosci. Res. 69 2002 72 79
36. C.S. Weickert, T.M. Hyde, B.K. Lipska, M.M. Herman, D.R. Weinberger, and J.E. Kleinman Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia Mol. Psychiatry 8 2003 592 610